Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome
Authors
Keywords
Multiple sclerosis, Blood plasma, B cells, Basophils, Steroids, Biomarkers, Blood, Pathogenesis
Journal
PLoS One
Volume 10, Issue 11, Pages e0143393
Publisher
Public Library of Science (PLoS)
Online
2015-11-25
DOI
10.1371/journal.pone.0143393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- The BAFF/APRIL system in SLE pathogenesis
- (2014) Fabien B. Vincent et al. Nature Reviews Rheumatology
- Treating multiple sclerosis with monoclonal antibodies: a 2013 update
- (2013) Annika Deiß et al. Expert Review of Neurotherapeutics
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease
- (2013) Gang Xin et al. NEPHROLOGY
- Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
- (2013) Klaus Lehmann-Horn et al. Therapeutic Advances in Neurological Disorders
- Belimumab – an anti-BLyS human monoclonal antibody for rheumatoid arthritis
- (2012) Xingzhong Jin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Serum BAFF Concentrations in Patients with Graves' Disease and Orbitopathy before and after Immunosuppressive Therapy
- (2012) Guia Vannucchi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse
- (2012) Honghao Wang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
- (2012) Markus C Kowarik et al. Journal of Neuroinflammation
- Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome
- (2012) Claire L Hirst et al. Multiple Sclerosis Journal
- Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
- (2012) Chao Quan et al. Multiple Sclerosis Journal
- Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
- (2011) Samia Ragheb et al. Multiple Sclerosis Journal
- Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity
- (2011) Miho Nagai et al. NEPHRON CLINICAL PRACTICE
- Overlapping and distinct mechanisms of action of multiple sclerosis therapies
- (2010) J.J. Graber et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Cerebrospinal BAFF and Epstein–Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases
- (2010) Diego Franciotta et al. JOURNAL OF NEUROIMMUNOLOGY
- Humoral autoimmunity in multiple sclerosis
- (2010) Edgar Meinl et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
- (2010) Adi Vaknin-Dembinsky et al. Multiple Sclerosis Journal
- Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
- (2010) Chris J Hedegaard et al. Multiple Sclerosis Journal
- Pathogenesis of Sjögrenʼs syndrome
- (2009) Nikolay P Nikolov et al. CURRENT OPINION IN RHEUMATOLOGY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome
- (2009) V. Fühlhuber et al. JOURNAL OF NEUROIMMUNOLOGY
- Impact of multiple sclerosis relapses on progression diminishes with time
- (2009) H. Tremlett et al. NEUROLOGY
- Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse
- (2009) Elizabeth Regina Comini Frota et al. NEUROSCIENCE LETTERS
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- Serum BAFF expression in patients with myasthenia gravis
- (2008) Jee Young Kim et al. JOURNAL OF NEUROIMMUNOLOGY
- Relapses in multiple sclerosis are age- and time-dependent
- (2008) H Tremlett et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Disease-modifying therapy in multiple sclerosis: Update and clinical implications
- (2008) D. S. Goodin NEUROLOGY
- Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
- (2007) Patrizia Scapini et al. IMMUNOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started